TY - JOUR
T1 - Once daily dosing of ceftriaxone and metronidazole in children with perforated appendicitis
AU - Lee, Ji Yeon
AU - Ally, Saudia
AU - Kelly, Brian
AU - Kays, David
AU - Thames, Lisa
N1 - Publisher Copyright:
© 2018, Pediatric Pharmacy Advocacy Group, Inc. All rights reserved.
PY - 2018/3/1
Y1 - 2018/3/1
N2 - OBJECTIVES: The aim of this study was to compare hospital length of stay and rate of infectious complications in children with perforated appendicitis based on the postoperative antibiotic administered. METHODS: This study was a retrospective analysis of children with perforated appendicitis who underwent an appendectomy at a large academic medical center from 2008 to 2013. The primary outcome was hospital length of stay. The secondary outcomes were rates of abscess formation, wound infection, and 30-day readmissions. RESULTS: One hundred and twenty-three patients were included. Sixty-six patients (53%) were administered ceftriaxone and metronidazole once daily; 57 (47%) were administered other antibiotic regimens, which consisted of single, double, or triple antibiotic therapy with a beta-lactam backbone. There was no difference between the groups in terms of postoperative length of stay (5.7 versus 5.8 days, p = 0.83), postoperative abscess rate (8% versus 4%, p = 0.57), postoperative wound infection rate (5% versus 2%, p = 0.73), and 30-day readmissions (3% versus 11%, p = 0.19). CONCLUSIONS: While there was no statistically significant difference in the outcomes evaluated, the rate of infectious complications was twofold higher in those given ceftriaxone and metronidazole than in others. A larger prospective randomized controlled trial is warranted to better understand the risks of using these agents.
AB - OBJECTIVES: The aim of this study was to compare hospital length of stay and rate of infectious complications in children with perforated appendicitis based on the postoperative antibiotic administered. METHODS: This study was a retrospective analysis of children with perforated appendicitis who underwent an appendectomy at a large academic medical center from 2008 to 2013. The primary outcome was hospital length of stay. The secondary outcomes were rates of abscess formation, wound infection, and 30-day readmissions. RESULTS: One hundred and twenty-three patients were included. Sixty-six patients (53%) were administered ceftriaxone and metronidazole once daily; 57 (47%) were administered other antibiotic regimens, which consisted of single, double, or triple antibiotic therapy with a beta-lactam backbone. There was no difference between the groups in terms of postoperative length of stay (5.7 versus 5.8 days, p = 0.83), postoperative abscess rate (8% versus 4%, p = 0.57), postoperative wound infection rate (5% versus 2%, p = 0.73), and 30-day readmissions (3% versus 11%, p = 0.19). CONCLUSIONS: While there was no statistically significant difference in the outcomes evaluated, the rate of infectious complications was twofold higher in those given ceftriaxone and metronidazole than in others. A larger prospective randomized controlled trial is warranted to better understand the risks of using these agents.
KW - Antibiotics
KW - Appendectomy
KW - Ceftriaxone
KW - Metronidazole
KW - Pediatrics
KW - Perforated appendicitis
UR - http://www.scopus.com/inward/record.url?scp=85036527873&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85036527873&partnerID=8YFLogxK
U2 - 10.5863/1551-6776-21.2.140
DO - 10.5863/1551-6776-21.2.140
M3 - Article
C2 - 27199621
AN - SCOPUS:85036527873
SN - 1551-6776
VL - 21
SP - 140
EP - 145
JO - Journal of Pediatric Pharmacology and Therapeutics
JF - Journal of Pediatric Pharmacology and Therapeutics
IS - 2
ER -